AI Science Tracker
EN

Artificial intelligence-based detection of small and intermediate-to-large lymphocytes for cytologic diagnosis of canine lymphoma.

Texas A&M University · 30 Aug 2026 · medicine

Discovery

Artificial intelligence-based detection of small and intermediate-to-large lymphocytes for cytologic diagnosis of canine lymphoma.

Source check: Source checked. Not independent scientific confirmation.

Finding: YOLOv11 transfer-learned on cytology images detects lymphocyte classes; 34 lymphoma and 11 non-lymphoma aspirates from 44 dogs, 25,761 cells/680 images; aspirate diagnosis inferred from intermediate/large cell proportion. Five-fold plus held-out test and cross-device configurations; test F1 86.02% overall, intermediate/large class precision 90.58%, recall 82.62%. Full Methods/Results read. Small retrospective veterinary sample.

Technology: YOLOv11, transfer-learned on cytology images, detects canine lymphoma lymphocyte classes; cell proportions support the aspirate-level diagnostic classification.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
YOLOv11, transfer-learned on cytology images, detects canine lymphoma lymphocyte classes; cell proportions support the aspirate-level diagnostic classification.
Test and result
YOLOv11 transfer-learned on cytology images detects lymphocyte classes; 34 lymphoma and 11 non-lymphoma aspirates from 44 dogs, 25,761 cells/680 images; aspirate diagnosis inferred from intermediate/large cell proportion. Five-fold plus held-out test and cross-device configurations; test F1 86.02% overall, intermediate/large class precision 90.58%, recall 82.62%. Full Methods/Results read. Small retrospective veterinary sample. Methods and Results establish cohort, comparator/ground truth and reported evaluation. Limitations are preserved in reason.
Limitation / still unknown
The study does not establish performance or consequences beyond the reported cohort, datasets, task or experimental setup.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://journals.sagepub.com/doi/full/10.1177/03009858261477051 · https://pubmed.ncbi.nlm.nih.gov/42669833/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.